| Released | Contributor | Author | Title | Pages | Price | | 22-Dec-2009 | New Constructs, LLC |
N/A
| TEVA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 | | 21-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 | | 21-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Market Research and Competitive Analysis 2010 | 730 |
$299 | | 21-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Plunkett's Health Care Technologies Overview 2010 (Summary) | 80 |
$199 | | 21-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Trends, Statistics & Analysis 2010 (Summary) | 98 |
$199 | | 21-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 | 447 |
$299 | | 21-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary) | 34 |
$199 | | 21-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for TEVA | 13 |
$25 | | 21-Dec-2009 | Market Edge |
N/A
| Market Edge Equity Research Report | 4 |
$10 | | 20-Dec-2009 | PriceTarget Research, Inc. |
N/A
| TEVA has a current Overall Rating of B (Positive). | 7 |
$25 |
|
0.49% Nasdaq 0.00%
Research Reports
